Michael Colaco
Michael Colaco is listed as an officer, manager or registered agent of 2 Florida companies, all active. Filings run from Jun 22, 2022 to Jan 28, 2026.
Updated
Get phone + email for Michael Colaco's 2 companies
Free account, no card. Contacts from official records and business websites.
- Companies
- 2
- Active / inactive
- 2 / 0
- Counties
- -
- Filed
- Jun 2022 - Jan 2026
Get the full report on Michael Colaco
One-time purchase, no account. Open it online, and download a PDF with the Full report.
- Companies
- Active
- Properties
- Licenses
- Loans
- Instant · One-time · No subscription
- Refund in 14 days if it shows no contact
See a sample
Sample report with fictional names and numbers. Your report shows the real filings for this owner.
Is this you? Keep your home address private.
| Business | Role | City | Filed | Contact |
|---|---|---|---|---|
| ATHEROLASE TECHNOLOGIES, INC. Corporation · President · Irvine · Jan 28, 2026 | President | Irvine | Jan 28, 2026 | |
| PATHFORCE TECHNOLOGIES, INC. Corporation · Director · Irvine · Jun 22, 2022 | Director | Irvine | Jun 22, 2022 |
About Michael Colaco's Florida companies
- What Florida companies is Michael Colaco associated with?
- Michael Colaco appears on the state filings of 2 Florida companies: ATHEROLASE TECHNOLOGIES, INC., PATHFORCE TECHNOLOGIES, INC..
- Are Michael Colaco's companies still active?
- Yes. All 2 companies are active in Florida Division of Corporations records.
- When did Michael Colaco file their Florida companies?
- The earliest filing is dated Jun 22, 2022 and the most recent Jan 28, 2026.
- How can I contact Michael Colaco?
- LLCDrop sells a one-time Owner Report on Michael Colaco for $9, with no account needed. It lists the Florida companies, officer roles and addresses on file, plus the phone number and email we hold for that name.
Matched on the exact officer name in Florida Division of Corporations filings. Different people can share a name, and very common names may list only part of their filings. Search Florida businesses.